Danish pharma huge Novo Nordisk teased promising early-stage trial final results of its experimental weight loss tablet amycretin, sending the corporation’s stock surging.Semaglutide (copyright) is usually a prescription drug which is applied to take care of sort two diabetic issues and might also support in weight loss. It’s part of a class of